Results

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	RMSD	Seq. Identity (%)	HETATM
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER D 924 THR F 922 THR F 923 GLY D 928 ASP D 932	1.51A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER D 924 THR F 922 THR F 923 GLY D 928 ASP D 932	1.55A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER D 924 THR F 922 THR F 923 GLY D 928 ASP D 932	1.57A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 924 ASN A1168 THR A 922 THR A 921 GLU A 918	1.43A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER D 924 THR F 922 THR F 923 GLY D 928 ASP D 932	1.54A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 10	GLN E1161 THR D 922 ILE E1164 THR E 922 ASP E 932	1.64A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 10	GLN D1161 THR F 922 ILE D1164 THR D 922 ASP D 932	1.64A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	1wof	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER B 1 ASN B 214 GLY B -1 GLY B 215 ASP B 216	1.60A	23.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	1wof	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	GLN A 110 ILE A 249 TYR A 209 THR A 257 ASP A 153	1.77A	23.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	1wof	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER B 1 ASN B 214 GLY B -1 GLY B 215 ASP B 216	1.67A	23.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER K 24 THR I 23 THR K 23 GLY K 28 ASP K 32	1.49A	9.36	None None None None NA K 205 (-2.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER K 24 ASN J 20 THR K 22 THR K 21 GLU K 18	1.50A	9.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER E 24 ASN D 20 THR E 22 THR E 21 GLU E 18	1.52A	9.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER I 24 THR G 22 THR G 23 GLY I 28 ASP I 32	1.48A	9.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER I 24 THR G 22 THR G 23 GLY I 28 ASP I 32	1.45A	9.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER I 24 THR G 22 THR G 23 GLY I 28 ASP I 32	1.49A	9.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER K 24 THR I 23 THR K 23 GLY K 28 ASP K 32	1.48A	9.36	None None None None NA K 205 (-2.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN REPLICASE POLYPROTEIN 1AB, LIGHT CHAIN (SARSr-CoV)	4 / 8	PHE F 97 GLN B 68 ILE B 73 GLY B 69	1.28A	19.83	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	2ajf	ACE2 (Homo sapiens)	5 / 9	TYR B 207 THR B 517 ILE B 513 THR B 449 ASP B 509	1.52A	17.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_A_9F2A302_1 (BETA-LACTAMASE)	2ajf	ACE2 (Homo sapiens)	5 / 9	TYR B 207 THR B 517 ILE B 513 THR B 449 ASP B 509	1.55A	17.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	2beq	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 924 THR B 923 THR C 923 GLY C 928 ASP C 932	1.47A	8.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	2beq	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 924 THR B 923 THR C 923 GLY C 928 ASP C 932	1.45A	8.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	2beq	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 924 THR B 922 THR B 923 GLY C 928 ASP C 932	1.44A	8.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	2beq	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 924 THR B 923 THR C 923 GLY C 928 ASP C 932	1.47A	8.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	2beq	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 924 THR B 922 THR B 923 GLY C 928 ASP C 932	1.48A	8.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER H 313 ASN G 270 THR G 297 GLY G 296 THR G 266	1.48A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER H 313 ASN G 270 THR G 297 GLY G 296 THR G 266	1.43A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER H 313 ASN G 270 THR G 297 GLY G 296 THR G 266	1.47A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER H 313 ASN G 270 THR G 297 GLY G 296 THR G 266	1.42A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER D 313 ARG C 294 GLY D 317 GLY C 288 ASP C 289	1.36A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER H 313 ASN G 270 THR G 297 GLY G 296 THR G 266	1.42A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER D 251 ASN D 270 ARG D 294 THR D 266 GLY D 296	1.52A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER H 313 ASN G 270 THR G 297 GLY G 296 THR G 266	1.45A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER H 313 ASN G 270 THR G 297 GLY G 296 THR G 266	1.44A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER H 313 ASN G 270 THR G 297 GLY G 296 THR G 266	1.47A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	GLN C 295 SER D 313 GLY D 317 GLY C 288 ASP C 289	1.36A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	2dd8	IGG HEAVY CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARSr-CoV)	5 / 12	ILE H 56 ASN H 58 THR S 487 GLY S 488 GLY H 50	1.52A	20.98	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	2fe8	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 12	SER B 115 SER B 104 ASN B 111 GLY B 288 ASP B 109	1.77A	20.49	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	2fyg	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 12	ILE A 99 THR A 56 THR A 51 GLY A 52 GLY A 127	1.55A	22.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	2fyg	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 12	ILE A 99 THR A 56 THR A 51 GLY A 52 GLY A 127	1.46A	22.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	2g9t	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 12	SER S 15 SER O 15 ARG S 78 THR O 12 THR S 12	1.75A	22.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	2g9t	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 12	ILE D 99 THR D 56 THR D 51 GLY D 52 GLY D 127	1.40A	22.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	2g9t	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 12	ILE D 99 THR D 56 THR D 51 GLY D 52 GLY D 127	1.48A	22.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	2ga6	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 10	ARG I 78 PRO J 59 THR M 49 THR J 47 ASP E 29	1.72A	22.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	2ga6	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 9	ARG I 78 PRO J 59 THR M 49 THR J 47 ASP E 29	1.77A	22.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	2ga6	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 10	ARG I 78 PRO J 59 THR M 49 THR J 47 ASP E 29	1.57A	22.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	2gdt	NSP1 (EC 3.4.22.-) P65 HOMOLOG LEADER PROTEIN (SARSr)	4 / 8	ARG A 88 GLN A 85 ILE A 84 GLY A 87	1.20A	16.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	2gdt	LEADER PROTEIN P65 HOMOLOG NSP1 (SARSr-CoV)	5 / 12	SER A 89 THR A 92 GLY A 87 GLY A 83 ASP A 82	1.33A	16.61	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	2ghw	ANTI-SCFV ANTIBODY, 80R (Homo sapiens)	5 / 12	SER D 139 SER D 154 THR D 152 THR D 234 GLY D 233	1.63A	24.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	2hsx	LEADER PROTEIN P65 HOMOLOG NSP1 (SARSr-CoV)	5 / 12	SER A 89 THR A 92 GLY A 87 GLY A 83 ASP A 82	1.60A	16.61	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	2hsx	LEADER PROTEIN P65 HOMOLOG NSP1 (SARSr-CoV)	5 / 12	SER A 89 THR A 92 GLY A 87 GLY A 83 ASP A 82	1.57A	16.61	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	2hsx	LEADER PROTEIN P65 HOMOLOG NSP1 (SARSr-CoV)	5 / 12	SER A 89 THR A 92 GLY A 87 GLY A 83 ASP A 82	1.61A	16.61	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	SER C 118 ILE C 79 PRO C 111 THR C 120 GLY C 140	1.44A	22.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	SER C 118 ILE C 79 PRO C 111 THR C 120 GLY C 140	1.45A	22.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	2pwx	3C-LIKE PROTEINASE (SARS-COV BJ01)	5 / 12	ILE A 136 ASN A 142 THR A 196 THR A 169 GLY A 170	1.39A	23.37	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	2pwx	3C-LIKE PROTEINASE (SARS-COV BJ01)	5 / 12	ILE A 136 ASN A 142 THR A 196 THR A 169 GLY A 170	1.37A	23.37	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	2qcy	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.48A	22.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	2qcy	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.50A	22.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	2qcy	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.45A	22.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	ILE A 280 ASN B 163 ARG B 61 THR A 285 GLY A 286	1.46A	22.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	ILE A 280 ASN B 163 ARG B 61 THR A 285 GLY A 286	1.53A	22.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 9	ILE E 295 PRO E 343 TYR E 342 THR E 340 ASP E 301	1.71A	22.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	2xyq	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	ASN A 64 ARG A 283 ARG A 86 GLY A 92 ASP A 125	1.70A	20.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	2xyr	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	ASN A 64 ARG A 86 GLY A 92 THR A 93 ASP A 125	1.40A	20.82	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	2xyr	NSP10 (SARSr-CoV)	5 / 12	ILE B 99 SER B 67 THR B 56 GLY B 52 GLY B 127	1.35A	22.97	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	2xyr	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	ASN A 64 ARG A 86 GLY A 92 THR A 93 ASP A 125	1.49A	20.82	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	2xyr	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	ASN A 64 ARG A 86 GLY A 92 THR A 93 ASP A 125	1.51A	20.82	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	2xyv	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	ARG A 283 ARG A 86 GLY A 92 THR A 93 ASP A 125	1.62A	20.82	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	3bgf	F26G19 FAB SPIKE PROTEIN S1 (Mus musculus; SARSr-CoV)	5 / 12	ASN H 60 ARG S 426 THR S 485 THR H 58 GLY H 49	1.57A	21.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	3bgf	F26G19 FAB SPIKE PROTEIN S1 (Mus musculus; SARSr-CoV)	5 / 12	ASN B 60 ARG A 426 THR A 485 THR B 58 GLY B 49	1.62A	21.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	3bgf	F26G19 FAB SPIKE PROTEIN S1 (Mus musculus; SARSr-CoV)	5 / 12	ASN B 60 ARG A 426 THR A 485 THR B 58 GLY B 49	1.60A	21.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	3d0g	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 10	GLN B 442 ILE B 446 TYR B 516 THR B 453 ASP B 367	1.40A	17.28	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	3d0g	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR F 475 THR B 27 PRO F 462 THR B 20 THR B 21	1.70A	22.71	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	3d0g	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR F 475 THR B 27 PRO F 462 THR B 20 THR B 21	1.71A	22.71	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	3d0g	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR F 475 THR B 27 PRO F 462 THR B 20 THR B 21	1.67A	22.71	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	3d0g	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 10	GLN B 442 ILE B 446 TYR B 516 THR B 453 ASP B 367	1.36A	17.28	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	3d0h	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR E 475 THR A 27 PRO E 462 THR A 20 THR A 21	1.64A	22.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	3d0h	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR E 475 THR A 27 PRO E 462 THR A 20 THR A 21	1.62A	22.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.51A	17.28	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 8	ASN B 432 PHE B 285 THR B 593 GLN B 598 ILE B 436	1.51A	19.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	3d0h	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR F 475 THR B 27 PRO F 462 THR B 20 THR B 21	1.65A	22.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_A_9F2A302_1 (BETA-LACTAMASE)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.53A	17.28	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	3e9s	NSP3 (SARSr-CoV)	5 / 12	SER A 115 SER A 104 ASN A 111 GLY A 288 ASP A 109	1.79A	20.00	OCS A 112 ( 4.7A) None OCS A 112 ( 4.0A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	3f9e	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ILE A 136 ASN A 142 THR A 196 THR A 169 GLY A 170	1.40A	23.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	3f9e	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ILE A 136 ASN A 142 THR A 196 THR A 169 GLY A 170	1.37A	23.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	3f9f	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.42A	23.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	3f9f	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.34A	23.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	3f9f	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.38A	23.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	3f9g	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER B 147 SER B 144 PRO B 122 GLY B 146 GLY B 29	1.52A	23.33	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	3f9g	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER B 147 SER B 144 PRO B 122 GLY B 146 GLY B 29	1.50A	23.33	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	3iwm	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ILE C 136 ASN C 133 THR C 175 ARG C 105 GLY C 183	1.53A	22.75	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	3m3t	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 0 ASN A 214 THR A 280 GLY A -1 GLY A 215	1.51A	22.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	3m3t	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 0 ASN A 214 THR A 280 GLY A -1 GLY A 215	1.51A	22.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	3m3t	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.40A	22.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	3m3t	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.43A	22.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	3m3t	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 147 SER A 144 PRO A 122 GLY A 146 GLY A 29	1.44A	22.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	3mj5	REPLICASE POLYPROTEIN 1A (SARSr-CoV)	5 / 12	SER A 86 THR B 199 THR B 201 GLY B 202 ASP A 77	1.60A	20.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	3mj5	REPLICASE POLYPROTEIN 1A (SARSr-CoV)	5 / 12	SER B 86 ASN B 157 THR A 199 THR A 201 GLY A 202	1.38A	20.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	3mj5	REPLICASE POLYPROTEIN 1A (SARSr-CoV)	5 / 12	ILE A 223 ASN B 110 GLY B 164 GLY B 161 ASP B 109	1.46A	20.12	None None GRM B 801 (-3.9A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	3mj5	REPLICASE POLYPROTEIN 1A (SARSr-CoV)	6 / 12	ILE A 223 ASN B 110 GLY B 164 GLY B 161 ASP B 109 GLU A 204	1.64A	20.12	None None GRM B 801 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	3r24	2'-O-METHYL TRANSFERASE (SARSr-CoV)	6 / 12	ASN A 64 ARG A 283 ARG A 86 GLY A 92 THR A 93 ASP A 125	1.72A	21.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	3r24	2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	ASN A 64 ARG A 86 GLY A 92 THR A 93 ASP A 125	1.54A	21.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	3r24	2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	ASN A 64 ARG A 86 GLY A 92 THR A 93 ASP A 125	1.44A	21.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	3r24	2'-O-METHYL TRANSFERASE (SARSr-CoV)	5 / 12	ASN A 64 ARG A 86 GLY A 92 THR A 93 ASP A 125	1.53A	21.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	3sci	ACE2 (Homo sapiens)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.53A	18.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	3sci	ACE2 (Homo sapiens)	5 / 10	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.50A	18.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_A_9F2A302_1 (BETA-LACTAMASE)	3sci	ACE2 (Homo sapiens)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.46A	18.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	3sci	ACE2 (Homo sapiens)	5 / 9	TYR B 207 THR B 517 ILE B 513 THR B 449 ASP B 509	1.52A	18.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	3sci	ACE2 (Homo sapiens)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.45A	18.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	3sci	ACE2 (Homo sapiens)	5 / 10	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.46A	18.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	3sck	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR F 475 THR B 27 PRO F 462 THR B 20 THR B 21	1.65A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.52A	18.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_A_9F2A302_1 (BETA-LACTAMASE)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.54A	18.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.61A	18.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	3sck	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR E 475 THR A 27 PRO E 462 THR A 20 THR A 21	1.63A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	3sck	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR E 475 THR A 27 PRO E 462 THR A 20 THR A 21	1.60A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	TYR A 207 THR A 517 ILE A 513 THR A 449 ASP A 509	1.52A	18.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	3scl	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 10	GLN B 442 ILE B 446 TYR B 516 THR B 453 ASP B 367	1.52A	18.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	3scl	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 10	GLN B 442 ILE B 446 TYR B 516 THR B 453 ASP B 367	1.57A	18.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZW_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	3snb	3C-LIKE PROTEINASE PEPTIDE ALDEHYDE INHIBITOR AC-DSFDQ-H (SARSr-CoV)	5 / 10	HIS A 164 ASP H 4 HIS A 41 THR A 135 HIS A 163	1.39A	22.19	None None ECC H 5 ( 4.9A) None ECC H 5 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	3vb3	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	SER A 1 ASN A 214 THR B 135 GLY B 170 ASP A 216	1.66A	22.75	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	4m0w	REPLICASE POLYPROTEIN 1A UBIQUITIN (Bos taurus; SARSr-CoV)	5 / 12	SER A 115 SER A 104 ASN A 111 GLY B 76 GLU A 264	1.73A	20.41	NA A 402 (-4.4A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	4ovz	PAPAIN-LIKE PROTEINASE (SARS-COV Urbani)	5 / 12	ASN A 157 THR B 198 THR B 201 GLY B 202 ASP A 77	1.64A	20.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.48A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.50A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 GLY A 211	1.49A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.49A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.47A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.50A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.51A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.50A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.47A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	SER A 247 SER A 167 THR A 308 GLY A 248 THR A 249	1.46A	22.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	4twy	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	CYH A 300 SER A 301 ASN A 214 GLY A 302 THR A 304	1.64A	22.75	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	5c8s	GUANINE-N7 METHYLTRANSFERASE NSP10 (SARSr-CoV)	4 / 8	THR D 21 GLN C 98 ILE C 55 GLY C 70	1.30A	21.11	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5c8s	NSP10 (SARSr-CoV)	5 / 12	PRO C 100 THR C 58 GLY C 50 THR C 51 GLY C 52	1.42A	22.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5c8s	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	SER D 112 THR D 173 THR D 113 GLY D 114 GLY D 110	1.67A	19.81	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5c8s	NSP10 (SARSr-CoV)	5 / 12	ASN A 62 THR A 58 GLY A 50 THR A 51 GLY A 52	1.79A	22.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5c8t	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	SER B 112 THR B 173 THR B 113 GLY B 114 GLY B 110	1.61A	19.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	5c8u	GUANINE-N7 METHYLTRANSFERASE NSP10 (SARSr-CoV)	5 / 9	ARG D 213 ILE D 201 TYR D 235 THR D 219 ASP C 29	1.80A	19.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_A_9F2A302_1 (BETA-LACTAMASE)	5c8u	GUANINE-N7 METHYLTRANSFERASE NSP10 (SARSr-CoV)	5 / 9	ARG D 213 ILE D 201 TYR D 235 THR D 219 ASP C 29	1.79A	19.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	5c8u	NSP10 (SARSr-CoV)	5 / 12	ILE C 99 THR C 56 THR C 51 GLY C 52 GLY C 127	1.26A	22.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	5c8u	GUANINE-N7 METHYLTRANSFERASE NSP10 (SARSr-CoV)	4 / 8	THR D 21 GLN C 98 ILE C 55 GLY C 70	0.95A	21.11	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	5c8u	NSP10 (SARSr-CoV)	5 / 12	ILE C 99 THR C 56 THR C 51 GLY C 52 GLY C 127	1.35A	22.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5e6j	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 12	SER D 115 SER D 104 ASN D 111 GLY D 288 ASP D 109	1.73A	20.42	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	ILE P 99 THR P 56 THR P 51 GLY P 52 GLY P 127	1.47A	23.32	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	4 / 8	THR B 21 GLN N 98 ILE N 55 GLY N 70	1.18A	20.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	PRO O 100 THR O 58 GLY O 50 THR O 51 GLY O 52	1.44A	23.32	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	ASN M 62 THR M 58 GLY M 50 THR M 51 GLY M 52	1.72A	23.32	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	SER D 112 THR D 173 THR D 113 GLY D 114 GLY D 110	1.68A	19.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	GLN C 168 SER A 171 SER A 230 THR A 215 GLY A 176	1.21A	19.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5tl6	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 12	SER D 115 SER D 104 ASN D 111 GLY D 288 ASP D 109	1.79A	20.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	5x4s	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 8	PHE A 103 THR A 67 ILE A 87 GLY A 255	1.31A	20.83	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER B 703 THR B 705 THR B1048 GLY B1028 GLY C 873	1.50A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER B 703 THR B 705 THR B1048 GLY B1028 GLY C 873	1.53A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER B 703 THR B 705 THR B1048 GLY B1028 GLY C 873	1.54A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER B 703 THR B 705 THR B1048 GLY B1028 GLY C 873	1.48A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER B 591 ILE B 674 THR B 588 GLY B 587 ASP B 649	1.52A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER B 703 THR B 705 THR B1048 GLY B1028 GLY C 873	1.47A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	5x59	S PROTEIN (MERS-CoV)	4 / 8	ASN A 981 THR A1121 ILE A 985 GLY B 963	1.24A	13.45	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	5x59	S PROTEIN (MERS-CoV)	5 / 12	SER A 966 ILE C1180 THR A 961 GLY A 963 GLY C 984	1.33A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	GLN C 769 THR B 705 THR B1048 GLY B1028 GLY C 871	1.25A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER A 248 SER A 95 PRO A 143 THR A 247 GLY A 246	1.30A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	4 / 8	PHE A 103 THR A 67 ILE A 87 GLY A 255	1.25A	14.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	ILE B 674 THR B 588 GLY B 587 THR B 585 GLY B 298	1.49A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER A 985 ARG A 977 THR A 988 GLY B 739 ASP B 976	1.75A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER A 248 SER A 95 PRO A 143 THR A 247 GLY A 246	1.32A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	ILE B 674 THR B 588 GLY B 587 THR B 585 GLY B 298	1.44A	12.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	5x5c	S PROTEIN (MERS-CoV)	5 / 12	SER A 966 ILE C1180 THR A 961 GLY A 963 GLY C 984	1.45A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	SER B 439 SER B 440 GLY B 578 THR B 579 GLY C 61	1.30A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	SER B 439 SER B 440 GLY B 578 THR B 579 GLY C 61	1.34A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	CYH B 828 SER B 829 SER A 350 THR A 70 GLY B 825	1.33A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	SER B 439 SER B 440 GLY B 578 THR B 579 GLY C 61	1.29A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	SER B 439 SER B 440 GLY B 578 THR B 579 GLY C 61	1.33A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	SER B 439 SER B 440 GLY B 578 THR B 579 GLY C 61	1.35A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	CYH B 828 SER B 829 SER A 350 THR A 70 GLY B 825	1.29A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	6 / 12	GLN C 280 SER B 439 SER B 440 GLY B 578 THR B 579 GLY C 61	1.58A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	SER B 439 SER B 440 GLY B 578 THR B 579 GLY C 61	1.34A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	5x5f	S PROTEIN (MERS-CoV)	5 / 12	SER B 439 SER B 440 GLY B 578 THR B 579 GLY C 61	1.32A	11.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 ASN A 230 GLY A 104 THR A 229 ASP A 85	1.37A	12.92	SER A 105 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A) ASP A 85 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 ASN A 230 GLY A 104 THR A 229 ASP A 85	1.32A	12.92	SER A 105 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A) ASP A 85 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 ASN A 230 GLY A 104 THR A 229 ASP A 85	1.34A	12.92	SER A 105 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A) ASP A 85 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 8	PHE A 103 THR A 67 ILE A 87 GLY A 255	1.17A	15.11	PHE A 103 ( 1.3A) THR A 67 ( 0.8A) ILE A 87 ( 0.6A) GLY A 255 ( 0.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 ASN A 230 GLY A 104 THR A 229 ASP A 85	1.39A	12.92	SER A 105 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A) ASP A 85 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 ASN A 230 GLY A 104 THR A 229 ASP A 85	1.37A	12.92	SER A 105 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A) ASP A 85 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 ASN A 230 GLY A 104 THR A 229 ASP A 85	1.37A	12.92	SER A 105 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A) ASP A 85 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 SER A 111 ASN A 230 GLY A 104 THR A 229	1.55A	12.92	SER A 105 ( 0.0A) SER A 111 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 ASN A 230 GLY A 104 THR A 229 ASP A 85	1.41A	12.92	SER A 105 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A) ASP A 85 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 105 ASN A 230 GLY A 104 THR A 229 ASP A 85	1.36A	12.92	SER A 105 ( 0.0A) ASN A 230 ( 0.6A) GLY A 104 ( 0.0A) THR A 229 ( 0.8A) ASP A 85 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5y3q	REPLICASE POLYPROTEIN 1A (SARSr-CoV)	5 / 12	SER A 115 SER A 104 ASN A 111 GLY A 288 ASP A 109	1.77A	19.82	NA A 405 (-2.9A) NA A 405 ( 3.9A) None NA A 405 (-3.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	5zvm	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER B 924 THR C 922 THR C 923 GLY B 928 ASP B 932	1.56A	15.18	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5zvm	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER B 924 THR C 922 THR C 923 GLY B 928 ASP B 932	1.52A	15.18	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	5zvm	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 924 THR B 923 THR A 923 GLY A 928 ASP A 932	1.59A	15.18	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	5zvm	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 924 THR A 923 THR C 923 GLY C 928 ASP C 932	1.57A	15.18	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	6acc	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLN C 769 THR A 705 THR A1048 GLY A1028 GLY C 871	1.34A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.50A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 8	THR C 229 GLN C 112 ILE C 226 GLY C 104	1.16A	15.11	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 9	THR C 55 PRO C 43 TYR C 42 THR C 215 ASP C 85	1.65A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_A_9F2A302_1 (BETA-LACTAMASE)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 9	THR C 55 PRO C 43 TYR C 42 THR C 215 ASP C 85	1.62A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6acg	ACE2 (Homo sapiens)	5 / 8	ASN D 432 PHE D 285 THR D 593 GLN D 598 ILE D 436	1.56A	19.84	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	6acg	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 10	GLN C 301 ARG C 306 THR C 616 THR C 260 THR C 261	1.35A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	6acg	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 10	GLN A 301 ARG A 306 THR A 616 THR A 260 THR A 261	1.33A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.49A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.50A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE C 674 THR C 588 GLY C 587 THR C 585 GLY C 298	1.38A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 728 ASN B 526 GLY B 534 THR B 533 ASP B 312	1.63A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE C 674 THR C 588 GLY C 587 THR C 585 GLY C 298	1.45A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE A 674 THR A 588 GLY A 587 THR A 585 GLY A 298	1.39A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.48A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.49A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE A 674 THR A 588 GLY A 587 THR A 585 GLY A 298	1.35A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE B 674 THR B 588 GLY B 587 THR B 585 GLY B 298	1.35A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 9	THR C 55 PRO C 43 TYR C 42 THR C 215 ASP C 85	1.62A	13.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.49A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.50A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.51A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.47A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.51A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.50A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.48A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	6 / 12	ILE B 674 SER B 591 THR B 588 GLY B 587 THR B 585 GLY B 298	1.78A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 8	PHE C 629 THR A 848 ILE C 656 GLY C 655	1.29A	15.03	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.49A	12.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6crw	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 8	ASN A 627 THR A 631 ILE A 637 GLY A 634	1.24A	15.03	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6crw	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER C 248 SER C 95 PRO C 143 THR C 247 GLY C 246	1.39A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.38A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.43A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.41A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER C 591 SER C 592 THR C 588 GLY C 587 THR C 585	1.40A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.35A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.38A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.40A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.37A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.42A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER B 591 SER B 592 THR B 588 GLY B 587 THR B 585	1.38A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	6cs0	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	ASN B 189 ARG A 342 GLY B 225 GLY B 192 ASP B 191	1.62A	12.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	6cs2	ACE2 (Homo sapiens)	5 / 9	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.50A	17.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_A_9F2A302_1 (BETA-LACTAMASE)	6cs2	ACE2 (Homo sapiens)	5 / 9	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.47A	17.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	6cs2	ACE2 (Homo sapiens)	5 / 10	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.49A	17.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	6cs2	ACE2 (Homo sapiens)	5 / 10	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.46A	17.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	6cs2	ACE2 (Homo sapiens)	5 / 9	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.44A	17.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6jyt	HELICASE (SARSr-CoV)	4 / 8	ARG A 490 GLN A 492 ILE A 493 GLY A 494	1.19A	20.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	6jyt	HELICASE (SARSr-CoV)	5 / 12	ASN B 116 GLY B 415 GLY B 118 ASP B 119 GLU B 418	1.79A	18.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	6jyt	HELICASE (SARSr-CoV)	5 / 12	GLN A 537 SER A 289 GLY A 287 GLY A 282 ASP A 401	1.40A	18.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6lzg	ACE2 (Homo sapiens)	5 / 8	ASN A 432 PHE A 285 THR A 593 GLN A 598 ILE A 436	1.64A	19.40	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	6m17	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	GLN C 274 GLY C 397 THR C 396 GLY C 395 ASP C 486	1.49A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6m18	ACE2 SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	ILE B 759 ARG B 766 LYS A 221 THR A 218 GLY B 764	1.47A	14.67	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	THR A 459 THR A 212 THR A 219 GLY A 220 GLU A 437	1.52A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	THR A 459 THR A 212 THR A 219 GLY A 220 GLU A 437	1.54A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6m18	ACE2 SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	ILE B 759 ARG B 766 LYS A 221 THR A 218 GLY B 764	1.49A	14.67	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	SER C 291 GLY C 93 GLY C 99 ASP C 445 GLU C 501	1.45A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	SER C 291 GLY C 93 GLY C 102 ASP C 445 GLU C 501	1.70A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	6m1d	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	SER A 291 SER A 290 GLY A 93 GLY A 99 ASP A 445	1.61A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	6m1d	ACE2 (Homo sapiens)	5 / 9	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.46A	14.67	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	6m1d	ACE2 (Homo sapiens)	5 / 9	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.40A	14.67	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6m1d	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	4 / 8	ASN C 515 PHE C 514 ILE C 518 GLY C 523	1.27A	18.84	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6m1d	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	SER A 106 ILE A 92 ARG A 97 GLY A 102 GLY A 99	1.43A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	6m1d	ACE2 (Homo sapiens)	5 / 10	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.39A	14.67	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6m1d	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	SER A 106 ILE A 92 ARG A 97 GLY A 102 GLY A 99	1.46A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6m1d	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	ILE A 107 SER A 105 ARG A 95 GLY A 99 GLY A 93	1.41A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	6m1d	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	SER A 291 SER A 290 GLY A 93 GLY A 99 ASP A 445	1.57A	17.56	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	6m1d	ACE2 (Homo sapiens)	5 / 9	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.45A	14.67	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	6m1d	ACE2 (Homo sapiens)	5 / 10	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.39A	14.67	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_A_9F2A302_1 (BETA-LACTAMASE)	6m1d	ACE2 (Homo sapiens)	5 / 9	TYR D 207 THR D 517 ILE D 513 THR D 449 ASP D 509	1.39A	14.67	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 8	THR A 869 GLN A 877 ILE A 878 GLY A 867	1.22A	14.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE A 674 THR A 588 GLY A 587 THR A 585 GLY A 298	1.50A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE A 674 SER A 591 THR A 588 GLY A 587 GLY A 298	1.44A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE C 674 SER C 591 THR C 588 GLY C 587 GLY C 298	1.46A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE C 674 SER C 591 THR C 588 GLY C 587 GLY C 298	1.39A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE A 674 THR A 588 GLY A 587 THR A 585 GLY A 298	1.51A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 703 THR C 705 THR C1048 GLY C1028 GLY B 873	1.49A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 703 THR C 705 THR C1048 GLY C1028 GLY B 873	1.55A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 703 THR C 705 THR C1048 GLY C1028 GLY B 873	1.52A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 703 THR C 705 THR C1048 GLY C1028 GLY B 873	1.54A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 703 THR C 705 THR C1048 GLY C1028 GLY B 873	1.50A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER C 703 THR C 705 THR C1048 GLY C1028 GLY B 873	1.55A	12.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	6nur	NSP12 (SARSr-CoV)	5 / 12	SER A 561 SER A 564 THR A 567 ARG A 569 GLY A 683	1.75A	14.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6nur	NSP12 (SARSr-CoV)	4 / 8	PHE A 480 THR A 591 ILE A 579 GLY A 590	1.19A	16.34	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	6nur	NSP12 NSP8 (SARSr-CoV)	5 / 12	SER A 343 ILE B 120 THR A 344 GLY A 345 GLY A 327	1.52A	14.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	6vw1	ACE2 (Homo sapiens)	5 / 10	GLN B 442 ILE B 446 TYR B 516 THR B 453 ASP B 367	1.44A	17.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	6vw1	ACE2 (Homo sapiens)	5 / 10	GLN B 442 ILE B 446 TYR B 516 THR B 453 ASP B 367	1.50A	17.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6vw1	ACE2 SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	PRO E 499 ASN E 501 GLY E 504 GLY A 354 ASP A 355	1.44A	23.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	6vw1	ACE2 SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLN A 96 PRO A 389 THR E 415 GLY E 416 ASP A 30	1.46A	17.44	None None BMA A 703 (-3.6A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	4 / 8	THR H 9 GLN H 6 ILE H 20 GLY H 8	1.28A	19.08	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6w41	CR3022 FAB LIGHT CHAIN (Homo sapiens)	4 / 8	PHE L 62 GLN L 79 ILE L 75 GLY L 16	1.46A	17.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6w41	CR3022 FAB LIGHT CHAIN (Homo sapiens)	5 / 12	SER L 63 ILE L 75 PRO L 59 THR L 72 GLY L 64	1.66A	21.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6w41	CR3022 FAB LIGHT CHAIN (Homo sapiens)	5 / 12	SER L 63 ILE L 75 PRO L 59 THR L 72 GLY L 64	1.61A	21.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	ILE H 20 THR H 87 THR H 110 THR H 9 GLY H 8	1.72A	19.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	ILE H 20 THR H 87 THR H 110 THR H 9 GLY H 8	1.76A	19.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	ILE H 98 SER H 96 THR H 31 GLY H 94 GLY H 35	1.58A	19.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	ILE H 98 SER H 96 THR H 31 GLY H 94 GLY H 35	1.68A	19.63	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.61A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_C_9F2C302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.70A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.72A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.64A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6yla	LIGHT CHAIN (Homo sapiens)	5 / 12	SER L 69 ILE L 81 PRO L 65 THR L 78 GLY L 70	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.69A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6yla	LIGHT CHAIN (Homo sapiens)	5 / 12	SER L 69 ILE L 81 PRO L 65 THR L 78 GLY L 70	1.69A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6yla	HEAVY CHAIN (Homo sapiens)	4 / 8	THR B 9 GLN B 6 ILE B 20 GLY B 8	1.29A	19.54	MLI B 304 (-4.0A) None None MLI H 305 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 10	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.65A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	ILE B 20 THR B 91 THR B 116 THR B 9 GLY B 8	1.71A	20.94	None None None MLI B 304 (-4.0A) MLI H 305 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6yla	LIGHT CHAIN (Homo sapiens)	5 / 12	SER C 69 ILE C 81 PRO C 65 THR C 78 GLY C 70	1.69A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.65A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 10	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.73A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_C_9F2C302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.62A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	ILE H 20 THR H 91 THR H 116 THR H 9 GLY H 8	1.71A	20.94	None None None None MLI B 304 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6yla	LIGHT CHAIN (Homo sapiens)	5 / 12	SER C 69 ILE C 81 PRO C 65 THR C 78 GLY C 70	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6yla	HEAVY CHAIN (Homo sapiens)	4 / 8	THR H 9 GLN H 6 ILE H 20 GLY H 8	1.27A	19.54	None None None MLI B 304 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	ILE B 20 THR B 91 THR B 116 THR B 9 GLY B 8	1.75A		None None None MLI B 304 (-4.0A) MLI H 305 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	ILE H 20 THR H 91 THR H 116 THR H 9 GLY H 8	1.74A		None None None None MLI B 304 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6ym0	HEAVY CHAIN (Homo sapiens)	4 / 8	THR H 9 GLN H 6 ILE H 20 GLY H 8	1.34A	19.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6ym0	LIGHT CHAIN (Homo sapiens)	5 / 12	SER L 69 ILE L 81 PRO L 65 THR L 78 GLY L 70	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6ym0	LIGHT CHAIN (Homo sapiens)	5 / 12	SER L 69 ILE L 81 PRO L 65 THR L 78 GLY L 70	1.72A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	6ym0	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.68A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	6ym0	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	5 / 9	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.70A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6yor	IGG H CHAIN (Homo sapiens)	4 / 8	THR B 9 GLN B 6 ILE B 20 GLY B 8	1.27A	19.54	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6yor	IGG L CHAIN (Homo sapiens)	5 / 12	SER L 69 ILE L 81 PRO L 65 THR L 78 GLY L 70	1.69A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 9	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.72A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	ILE B 20 THR B 91 THR B 116 THR B 9 GLY B 8	1.74A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6yor	IGG L CHAIN (Homo sapiens)	5 / 12	SER L 69 ILE L 81 PRO L 65 THR L 78 GLY L 70	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 10	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.78A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	6yor	IGG L CHAIN (Homo sapiens)	5 / 12	SER C 69 ILE C 81 PRO C 65 THR C 78 GLY C 70	1.69A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	ILE B 20 THR B 91 THR B 116 THR B 9 GLY B 8	1.71A	20.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 9	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.69A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZX_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	6yor	IGG H CHAIN (Homo sapiens)	4 / 8	THR H 9 GLN H 6 ILE H 20 GLY H 8	1.27A	19.54	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	ILE H 20 THR H 91 THR H 116 THR H 9 GLY H 8	1.73A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_A_9F2A302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 9	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.69A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 10	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.73A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_C_9F2C302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 10	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.73A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_C_9F2C302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 10	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.78A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_C_9F2C302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 9	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.70A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_C_9F2C302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 9	TYR C 102 THR B 104 ILE B 50 TYR B 32 THR B 31	1.70A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_A_9F2A302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	5 / 9	TYR L 102 THR H 104 ILE H 50 TYR H 32 THR H 31	1.72A	20.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	6yor	IGG L CHAIN (Homo sapiens)	5 / 12	SER C 69 ILE C 81 PRO C 65 THR C 78 GLY C 70	1.61A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	ILE H 20 THR H 91 THR H 116 THR H 9 GLY H 8	1.69A	20.94	None